Search research articles
Contact Us
Filters
Showing results (171-180 of 186) with videos related to
Page
of 19
Sort By:
Oncogene
|
January 24, 2019
A novel small molecule that kills a subset of MLL-rearranged leukemia cells by inducing mitochondrial dysfunction
Klaartje Somers, Victoria W Wen, Shiloh M C Middlemiss, et al.
Molecular Cancer Therapeutics
|
March 18, 2026
Comprehensive multi-platform tyrosine kinase profiling reveals novel actionable FGFR aberrations across sarcomas affecting the young
Ashleigh M Fordham, Lauren M Brown, Chelsea Mayoh, et al.
Cell Death & Disease
|
March 13, 2021
Preclinical small molecule WEHI-7326 overcomes drug resistance and elicits response in patient-derived xenograft models of human treatment-refractory tumors
Christoph Grohmann, Francesca Walker, Mark Devlin, et al.
Molecular Cancer Therapeutics
|
April 27, 2026
Comprehensive Multiplatform Tyrosine Kinase Profiling Reveals Novel Actionable FGFR Aberrations across Sarcomas Affecting the Young
Ashleigh M Fordham, Lauren M Brown, Chelsea Mayoh, et al.
Nature Communications
|
June 13, 2026
The PLK4 inhibitor RP-1664 demonstrates potent efficacy in neuroblastoma preclinical models through a dual mechanism of sensitivity
Isabel Soria-Bretones, Matias Casás-Selves, Minu Samanta, et al.
Nature Communications
|
July 11, 2024
The transcriptional co-repressor Runx1t1 is essential for MYCN-driven neuroblastoma tumorigenesis
Jayne E Murray, Emanuele Valli, Giorgio Milazzo, et al.
Genome Medicine
|
April 4, 2023
A novel transcriptional signature identifies T-cell infiltration in high-risk paediatric cancer
Chelsea Mayoh, Andrew J Gifford, Rachael Terry, et al.
Nature Medicine
|
June 6, 2024
Precision-guided treatment in high-risk pediatric cancers
Loretta M S Lau, Dong-Anh Khuong-Quang, Chelsea Mayoh, et al.
Gynecologic Oncology
|
August 7, 2013
ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: a comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas
Sharon E Johnatty, Jonathan Beesley, Bo Gao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 13, 2026
Integrated germline and somatic molecular profiling to detect cancer predisposition has a high clinical impact in poor-prognosis paediatric cancer
Noemi A Fuentes-Bolanos, Eliza Courtney, Chelsea Mayoh, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 186) with videos related to
Sort By:
Page
of 19
Oncogene
|
January 24, 2019
A novel small molecule that kills a subset of MLL-rearranged leukemia cells by inducing mitochondrial dysfunction
Klaartje Somers, Victoria W Wen, Shiloh M C Middlemiss, et al.
Molecular Cancer Therapeutics
|
March 18, 2026
Comprehensive multi-platform tyrosine kinase profiling reveals novel actionable FGFR aberrations across sarcomas affecting the young
Ashleigh M Fordham, Lauren M Brown, Chelsea Mayoh, et al.
Cell Death & Disease
|
March 13, 2021
Preclinical small molecule WEHI-7326 overcomes drug resistance and elicits response in patient-derived xenograft models of human treatment-refractory tumors
Christoph Grohmann, Francesca Walker, Mark Devlin, et al.
Molecular Cancer Therapeutics
|
April 27, 2026
Comprehensive Multiplatform Tyrosine Kinase Profiling Reveals Novel Actionable FGFR Aberrations across Sarcomas Affecting the Young
Ashleigh M Fordham, Lauren M Brown, Chelsea Mayoh, et al.
Nature Communications
|
June 13, 2026
The PLK4 inhibitor RP-1664 demonstrates potent efficacy in neuroblastoma preclinical models through a dual mechanism of sensitivity
Isabel Soria-Bretones, Matias Casás-Selves, Minu Samanta, et al.
Nature Communications
|
July 11, 2024
The transcriptional co-repressor Runx1t1 is essential for MYCN-driven neuroblastoma tumorigenesis
Jayne E Murray, Emanuele Valli, Giorgio Milazzo, et al.
Genome Medicine
|
April 4, 2023
A novel transcriptional signature identifies T-cell infiltration in high-risk paediatric cancer
Chelsea Mayoh, Andrew J Gifford, Rachael Terry, et al.
Nature Medicine
|
June 6, 2024
Precision-guided treatment in high-risk pediatric cancers
Loretta M S Lau, Dong-Anh Khuong-Quang, Chelsea Mayoh, et al.
Gynecologic Oncology
|
August 7, 2013
ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: a comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas
Sharon E Johnatty, Jonathan Beesley, Bo Gao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 13, 2026
Integrated germline and somatic molecular profiling to detect cancer predisposition has a high clinical impact in poor-prognosis paediatric cancer
Noemi A Fuentes-Bolanos, Eliza Courtney, Chelsea Mayoh, et al.
Page
of 19